NDA 18672, held by Pohl Boskamp. Nitroglycerin.
As of Nov 14, 2026, NDA 18672 (Nitronal, Nitro Iv), held by Pohl Boskamp, was not approved, with 0 approved supplements and 0 published complete response letters.
| Nitronal1MG/ML · injectable;injection | Nitroglycerin | Discontinued |
| Nitro Iv5MG/ML · injectable;injection | Nitroglycerin | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
